- Home
- OCSL vs RVMDW Comparison
OCSL vs RVMDW Comparison
Compare OCSL & RVMDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCSL
- RVMDW
- Stock Information
- Founded
- OCSL 2007
- RVMDW N/A
- Country
- OCSL United States
- RVMDW United States
- Employees
- OCSL N/A
- RVMDW 490
- Industry
- OCSL Finance: Consumer Services
- RVMDW
- Sector
- OCSL Finance
- RVMDW
- Exchange
- OCSL Nasdaq
- RVMDW Nasdaq
- Market Cap
- OCSL 1.3B
- RVMDW N/A
- IPO Year
- OCSL 2008
- RVMDW N/A
- Fundamental
- Price
- OCSL $15.22
- RVMDW $0.18
- Analyst Decision
- OCSL Hold
- RVMDW
- Analyst Count
- OCSL 9
- RVMDW 0
- Target Price
- OCSL $17.29
- RVMDW N/A
- AVG Volume (30 Days)
- OCSL 1.1M
- RVMDW N/A
- Earning Date
- OCSL 01-30-2025
- RVMDW N/A
- Dividend Yield
- OCSL 14.40%
- RVMDW N/A
- EPS Growth
- OCSL N/A
- RVMDW N/A
- EPS
- OCSL 0.72
- RVMDW N/A
- Revenue
- OCSL $381,665,000.00
- RVMDW N/A
- Revenue This Year
- OCSL N/A
- RVMDW N/A
- Revenue Next Year
- OCSL N/A
- RVMDW N/A
- P/E Ratio
- OCSL $21.22
- RVMDW N/A
- Revenue Growth
- OCSL 0.63
- RVMDW N/A
- 52 Week Low
- OCSL $14.95
- RVMDW N/A
- 52 Week High
- OCSL $21.64
- RVMDW N/A
- Technical
- Relative Strength Index (RSI)
- OCSL 43.19
- RVMDW N/A
- Support Level
- OCSL $14.95
- RVMDW N/A
- Resistance Level
- OCSL $15.35
- RVMDW N/A
- Average True Range (ATR)
- OCSL 0.23
- RVMDW 0.00
- MACD
- OCSL -0.01
- RVMDW 0.00
- Stochastic Oscillator
- OCSL 31.52
- RVMDW 0.00
About OCSL Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.
About RVMDW Revolution Medicines Inc. Warrant
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.